Latest News by Industry
DUBLIN--(BUSINESS WIRE)--Oct 4, 2022--
The "Veterinary Infectious Disease Diagnostics Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.
The global veterinary infectious disease diagnostics market is expected to grow from $1.44 billion in 2021 to $1.63 billion in 2022 at a compound annual growth rate (CAGR) of 13%. The veterinary infectious disease diagnostics market is expected to grow to $2.36 billion in 2026 at a CAGR of 9.7%.
North America was the largest region in the veterinary disease diagnostics market in 2021. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary infectious disease diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The increasing incidence of transboundary and zoonotic diseases such as rabies is expected to propel the growth of the veterinary infectious disease diagnostics market going forward. Zoonoses are diseases and infections that are transferred spontaneously between humans and vertebrate animals.
Veterinary infectious disease diagnostics are used to detect rabies in pets and animals. These devices are used to prevent animals from causing death. For instance, in 2021, according to the World Health Organization (WHO), a Swiss-based government agency, rabies disease was found in over 150 nations and territories.
Dogs are the most common source of human rabies deaths, accounting for up to 99% of all rabies transmissions. Children under the age of 15 make up 40% of those bitten by suspected rabid animals. Infection kills tens of thousands of people every year, mostly in Asia and Africa. Therefore, the increasing incidence of transboundary and zoonotic diseases is driving the growth of the veterinary infectious disease diagnostics market.
Technological advancements have emerged as the key trend gaining popularity in the veterinary infectious disease diagnostics market. Major companies operating in the veterinary infectious disease diagnostics market are introducing new technological innovations to sustain their position in the market.
For instance, in 2020, LexaGene, a US-based company operating in veterinary infectious disease diagnostics, released MiQLab, a gold standard diagnostic equipment that uses a unique RT-qPCR-based technology to evaluate each sample's contents for up to 27 distinct pathogens in under an hour. MiQLab is unique in that it is open-source, allowing users to customize existing tests and build new ones with ease. If a new test is necessary due to a mutation, the open-access functionality allows new tests to be developed quickly on LexaGene's MiQLab system.
In January 2020, Heska Corp., a US-based company that manufactures point-of-care diagnostics equipment and imaging devices, acquired Scil Animal Care Co. for a deal amount of $110 million. With this acquisition, Heska Corp.'s overseas market share increased to 40% in Germany and 30% in Spain and France, which also expanded the company's animal care offering. Social Animal Care is a France based company that manufactures veterinary diagnostic devices.
Scope
Markets Covered:
1) By Infection Type: Viral Infections; Bacterial Infections; Parasitic Infections; Other Infections
2) By Animal Type: Companion Animal; Food-Producing animals
3) By Technology: Immunodiagnostics; Molecular Diagnostic; Other Technologies
4) By End User: Reference Laboratories; Veterinary Hospitals and Clinics; Point of Care; Research Institutes and Universities; Other End Users
Key Topics Covered:
1. Executive Summary
2. Veterinary Infectious Disease Diagnostics Market Characteristics
3. Veterinary Infectious Disease Diagnostics Market Trends And Strategies
4. Impact Of COVID-19 On Veterinary Infectious Disease Diagnostics
5. Veterinary Infectious Disease Diagnostics Market Size And Growth
6. Veterinary Infectious Disease Diagnostics Market Segmentation
7. Veterinary Infectious Disease Diagnostics Market Regional And Country Analysis
8. Asia-Pacific Veterinary Infectious Disease Diagnostics Market
9. China Veterinary Infectious Disease Diagnostics Market
10. India Veterinary Infectious Disease Diagnostics Market
11. Japan Veterinary Infectious Disease Diagnostics Market
12. Australia Veterinary Infectious Disease Diagnostics Market
13. Indonesia Veterinary Infectious Disease Diagnostics Market
14. South Korea Veterinary Infectious Disease Diagnostics Market
15. Western Europe Veterinary Infectious Disease Diagnostics Market
16. UK Veterinary Infectious Disease Diagnostics Market
17. Germany Veterinary Infectious Disease Diagnostics Market
18. France Veterinary Infectious Disease Diagnostics Market
19. Eastern Europe Veterinary Infectious Disease Diagnostics Market
20. Russia Veterinary Infectious Disease Diagnostics Market
21. North America Veterinary Infectious Disease Diagnostics Market
22. USA Veterinary Infectious Disease Diagnostics Market
23. South America Veterinary Infectious Disease Diagnostics Market
24. Brazil Veterinary Infectious Disease Diagnostics Market
25. Middle East Veterinary Infectious Disease Diagnostics Market
26. Africa Veterinary Infectious Disease Diagnostics Market
27. Veterinary Infectious Disease Diagnostics Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Veterinary Infectious Disease Diagnostics Market
29. Veterinary Infectious Disease Diagnostics Market Future Outlook and Potential Analysis
30. Appendix
Companies Mentioned
For more information about this report visit https://www.researchandmarkets.com/r/81v71h
View source version on businesswire.com:https://www.businesswire.com/news/home/20221004005835/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: VETERINARY HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 10/04/2022 10:06 AM/DISC: 10/04/2022 10:06 AM
http://www.businesswire.com/news/home/20221004005835/en